Skip to main content
$7.39 -$0.57 (-7.2%)

04:00 PM EDT on 04/20/21

Chromadex Corp. (NASDAQ:CDXC)

CAPS Rating: 1 out of 5

Current Price $7.39 Mkt Cap $531.4M
Open $7.98 P/E Ratio 0.00
Prev. Close $7.96 Div. (Yield) $0.00 (0.0%)
Daily Range $7.35 - $8.00 Volume 1,278,550
52-Wk Range $3.82 - $23.66 Avg. Daily Vol. 5,666,463

Caps

How do you think NASDAQ:CDXC will perform against the market?

Add Stock to CAPS Watchlist

All Players

26 Outperform
33 Underperform
 

All-Star Players

3 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CDXC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

DrChimera (63.41)
Submitted January 07, 2018

Great Product

allstar31 (99.95)
Submitted July 25, 2011

Stock Pump and Dump. It is paying people to boost its stock, though it doesn't even have a product in stores yet, though later this year it is supposed to have some crappy vitamin on the shelves of GNC.

NASDAQ:CDXC VS S&P 500 (SPY)

NASDAQ:CDXC Summary

Fools bullish on NASDAQ:CDXC are also bullish on:

Fools bearish on NASDAQ:CDXC are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CDXC.

Recs

0
Member Avatar TreasureCoastJLF (< 20) Submitted: 2/19/2021 11:49:15 AM : Outperform Start Price: $7.94 NASDAQ:CDXC Score: -12.10

Strong research pipeline. Longevity is on everyone's mind.

Recs

2
Member Avatar DrChimera (63.41) Submitted: 1/7/2018 2:11:11 AM : Outperform Start Price: $6.38 NASDAQ:CDXC Score: -34.98

Great Product

Recs

0
Member Avatar futurist123 (< 20) Submitted: 2/11/2017 7:21:20 PM : Outperform Start Price: $2.75 NASDAQ:CDXC Score: +91.13

I personally bought this stock at $2.42...just getting this into CAPS now.

I like the product story behind Niagen. As of now, it seems to be a key focus and I like the story regarding how it could be a billion dollar ingredient via inclusion in other products.

The stock had two bad storylines over the course of the last year. It was hit with what amounted to a smear article on seekingalpha, which saw a precipitous drop. And recently, it announced it was suing its largest customer. I feel that customer does not have leverage over CDXC, and thus the lawsuit should be settled and return to normal operating procedure, as CDXC supplies the key ingredients for its only product as of now.

Add to all of this that the company is advised by a Nobel laureate, and we see an undervaluation.

Leaderboard

Find the members with the highest scoring picks in CDXC.

Score Leader

loangolfer

loangolfer (< 20) Score: +175.97

The Score Leader is the player with the highest score across all their picks in CDXC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
loangolfer < 20 1/3/2013 11/14/2019 Outperform NS $1.61 +358.29% +182.33% +175.97 0 Comment
allstar31 99.95 7/25/2011 Underperform 5Y $5.25 +40.76% +209.20% +168.44 2 Comments
Under5 69.57 4/5/2017 Outperform 5Y $2.52 +193.84% +73.85% +119.98 0 Comment
ice23bear < 20 12/10/2018 Outperform 5Y $2.96 +149.66% +58.01% +91.65 0 Comment
futurist123 < 20 2/13/2017 Outperform 5Y $2.75 +168.73% +77.60% +91.13 1 Comment
extranatty 98.38 2/13/2017 Outperform 5Y $2.75 +168.73% +77.60% +91.13 0 Comment
optofonik < 20 2/13/2013 Outperform 5Y $2.04 +262.25% +171.20% +91.05 0 Comment
snowgoon42 94.38 4/6/2015 Underperform NS $5.04 +46.63% +99.66% +53.03 0 Comment
warrenout2 36.75 11/26/2012 Outperform 5Y $2.16 +242.13% +193.05% +49.08 0 Comment
GoldMiner20 72.45 1/20/2021 Outperform 5Y $4.71 +56.90% +8.15% +48.75 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CDXC.